ESC Premium Access

Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Hassaan Arshad

New Jersey Medical School, Newark (United States of America)
0 follower

9 more presentations in this session

Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)


Left ventricular stiffness assessed by diastolic wall strain predicts infrequent atrial fibrillation

Speaker: Doctor H. Kishima (Nishinomiya, JP)


The impact of elective cardioversion for atrial fibrillation in heart failure patients

Speaker: Doctor J. Graby (Bath, GB)


Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

Speaker: Professor R. Dabrowski (Warsaw, PL)


MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea

Speaker: Doctor K. Kadhim (Adelaide, AU)


Access the full session

Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Speakers: Doctor H. Arshad, Associate Professor M. Dzeshka, Doctor H. Kishima, Doctor J. Graby, Professor R. Dabrowski...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb